ArticleAlzheimer's & dementia (New York, N. Y.)2017
Cross-validation of optimized composites for preclinical Alzheimer's disease.
Michael C Donohue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it